Jason Bouvier
Stock Analyst at Scotiabank
(2.05)
# 2,902
Out of 4,761 analysts
9
Total ratings
50%
Success rate
6.6%
Average return
Main Sectors:
Stocks Rated by Jason Bouvier
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
OVV Ovintiv | Maintains: Sector Outperform | $50 → $53 | $43.31 | +22.37% | 3 | Nov 18, 2024 | |
IMO Imperial Oil | Downgrades: Sector Perform | $110 | $69.81 | +57.57% | 2 | Sep 25, 2024 | |
SU Suncor Energy | Maintains: Sector Perform | $61 → $60 | $39.49 | +51.94% | 1 | Jul 12, 2024 | |
CVE Cenovus Energy | Maintains: Sector Outperform | $35 → $34 | $14.59 | +133.04% | 1 | Jul 12, 2024 | |
CNQ Canadian Natural Resources | Maintains: Sector Perform | $114 → $57 | $29.97 | +90.19% | 1 | Jun 11, 2024 | |
IKNA Ikena Oncology | Initiates: Buy | n/a | $1.39 | - | 1 | Apr 20, 2021 |
Ovintiv
Nov 18, 2024
Maintains: Sector Outperform
Price Target: $50 → $53
Current: $43.31
Upside: +22.37%
Imperial Oil
Sep 25, 2024
Downgrades: Sector Perform
Price Target: $110
Current: $69.81
Upside: +57.57%
Suncor Energy
Jul 12, 2024
Maintains: Sector Perform
Price Target: $61 → $60
Current: $39.49
Upside: +51.94%
Cenovus Energy
Jul 12, 2024
Maintains: Sector Outperform
Price Target: $35 → $34
Current: $14.59
Upside: +133.04%
Canadian Natural Resources
Jun 11, 2024
Maintains: Sector Perform
Price Target: $114 → $57
Current: $29.97
Upside: +90.19%
Ikena Oncology
Apr 20, 2021
Initiates: Buy
Price Target: n/a
Current: $1.39
Upside: -